Stocks › CDNA

CareDx, Inc.

CDNA·Nasdaq·United States United States·USD
$70.00
-1.92 (-2.67%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CDNA
CareDx, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CDNAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CDNA by members of U.S. Congress · 14 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Daniel S. GoldmanDaniel S. GoldmanHouse · D · NY CDNACareDx, Inc. · Stock Sale
$1,001 - $15,000
Apr 17, 2023 Mar 6, 2023 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Sale
$1,001 - $15,000
Aug 26, 2021 Jan 11, 2021 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Purchase
$1,001 - $15,000
Aug 26, 2021 Dec 29, 2020 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Purchase
$1,001 - $15,000
Aug 26, 2021 Dec 23, 2020 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Sale
$1,001 - $15,000
Aug 26, 2021 Oct 9, 2020 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Purchase
$1,001 - $15,000
Aug 26, 2021 Nov 16, 2020 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Purchase
$1,001 - $15,000
Aug 26, 2021 Dec 7, 2020 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Sale
$15,001 - $50,000
Aug 26, 2021 Jan 6, 2021 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Sale
$1,001 -
Aug 26, 2021 Jan 8, 2021 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Purchase
$15,001 - $50,000
Apr 10, 2021 Mar 2, 2021 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Sale
$15,001 - $50,000
Mar 5, 2021 Mar 11, 2019 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Purchase
$1,001 - $15,000
Mar 5, 2021 Apr 1, 2019 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Sale
$1,001 - $15,000
Mar 5, 2021 Jun 17, 2019 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ CDNACareDx, Inc. · Stock Sale
$1,001 - $15,000
Mar 5, 2021 Jun 19, 2019 Filing ↗

Whale Activity

Position changes in CDNA reported for 2026-09-30 by 329 institutional filers
Increased: 88New: 96Held: 24Decreased: 86Closed: 22No prior filing: 13
  • Increased88
  • New96
  • Held24
  • Decreased86
  • Closed22
  • No prior filing13
FilerSharesValueChange
BlackRock, Inc.4.9M$316.7Mincreased
STATE STREET CORP2.6M$170.5Mincreased
VANGUARD CAPITAL MANAGEMENT LLC2.2M$142.6Mdecreased
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.1M$133.9Mincreased
Blue Water Life Science Advisors, LP1.7M$113.1Mincreased
ARK Investment Management LLC1.6M$104.6Mdecreased
BAMCO INC /NY/1.5M$97.5Mdecreased
GEODE CAPITAL MANAGEMENT, LLC1.5M$96.3Mincreased
Divisadero Street Capital Management, LP1.4M$92.3Mincreased
Chevy Chase Trust Holdings, LLC1.4M$87.9Mdecreased
FRANKLIN TEMPLETON INC985.7K$84.6Mincreased
D. E. Shaw & Co., Inc.1.3M$83.4Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CDNA insiders, by quarter · Form 4
-250.0K-125.0K0125.0K250.0K2025 Q1: -23.5K2025 Q12025 Q2: -133.0K2025 Q22025 Q3: -12.7K2025 Q32025 Q4: -9,9812025 Q42026 Q1: -34.1K2026 Q12026 Q2: -120.2K2026 Q22026 Q3: -230.2K2026 Q32026 Q4: -87.2K2026 Q4

Recent Insider Transactions

1,282 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Riggsbee Richard BryanDirector · Director Sale −800 $75.95 $61K Nov 16, 2026 Form 4 ↗
Riggsbee Richard BryanDirector · Director Sale −400 $77.02 $31K Nov 16, 2026 Form 4 ↗
Riggsbee Richard BryanDirector · Director Sale −2,418 $74.02 $179K Nov 16, 2026 Form 4 ↗
Riggsbee Richard BryanDirector · Director Sale −1,667 $74.74 $125K Nov 16, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −800 $78.78 $63K Nov 12, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −1,297 $79.61 $103K Nov 12, 2026 Form 4 ↗
Goldberg MichaelDirector · Director Sale −8,024 $79.32 $636K Nov 12, 2026 Form 4 ↗
Goldberg MichaelDirector · Director Sale −3,547 $78.32 $278K Nov 12, 2026 Form 4 ↗
Goldberg MichaelDirector · Director Sale −2,229 $79.85 $178K Nov 12, 2026 Form 4 ↗
Novack Jeffrey AdamSecretary and General Counsel Sale −900 $83.33 $75K Nov 10, 2026 Form 4 ↗
Novack Jeffrey AdamSecretary and General Counsel Sale −2,996 $80.47 $241K Nov 10, 2026 Form 4 ↗
Novack Jeffrey AdamSecretary and General Counsel Sale −200 $81.05 $16K Nov 10, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −7,415 $79.49 $589K Nov 5, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −6,897 $78.59 $542K Nov 5, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −600 $83.60 $50K Nov 5, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −3,403 $80.38 $274K Nov 5, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −300 $82.08 $25K Nov 5, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −28.3K $76.55 $2.2M Nov 5, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −2,710 $81.40 $221K Nov 5, 2026 Form 4 ↗
Kennedy KeithCFO & COO Sale −12.4K $77.42 $958K Nov 5, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CDNA · SEC Form N-PORT
FundSharesValue% of fundAs of
ARK Genomic Revolution ETF
ARK ETF Trust
1.5M$66.9M4.30%Jul 31, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.6M$44.3M0.00%Jun 30, 2026
BARON DISCOVERY FUND
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)
1.4M$39.1M2.14%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
1.3M$38.2M0.05%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF
SPDR SERIES TRUST
1.1M$32.6M0.30%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
560.8K$24.5M0.07%Jul 31, 2026
Strategic Advisers U.S. Total Stock Fund
Fidelity Rutland Square Trust II
464.1K$23.3M0.02%Aug 31, 2026
First Eagle Small Cap Opportunity Fund
First Eagle Funds
485.1K$21.2M0.73%Jul 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
588.5K$16.8M0.02%Jun 30, 2026
Column Small Cap Select Fund
Trust for Professional Managers
326.3K$16.4M0.85%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list CDNA's shares (CUSIP 14167L103), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 2.6M shares5.1%
    Nov 10, 2026 · ↗
  • Baron Capital Management, Inc.SCHEDULE 13G/A · passive (13G) · 274.4K shares0.5%
    Aug 14, 2026 · ↗
  • Ronald BaronSCHEDULE 13G/A · passive (13G) · 1.9M shares3.8%
    Aug 14, 2026 · ↗
  • Baron Capital Group, Inc.SCHEDULE 13G/A · passive (13G) · 1.9M shares3.8%
    Aug 14, 2026 · ↗
  • BAMCO INC /NY/SCHEDULE 13G/A · passive (13G) · 1.7M shares3.2%
    Aug 14, 2026 · ↗
  • Neil GagnonSCHEDULE 13G/A · passive (13G) · 2.3M shares4.4%
    Aug 7, 2026 · ↗
  • Gagnon Advisors, LLCSCHEDULE 13G/A · passive (13G) · 408.8K shares0.8%
    Aug 7, 2026 · ↗
  • Gagnon Securities LLCSCHEDULE 13G/A · passive (13G) · 1.6M shares3.2%
    Aug 7, 2026 · ↗
  • STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 2.5M shares4.8%
    Aug 7, 2026 · ↗
  • BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 4.7M shares9.0%
    Jul 27, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming caredx as client
$0$250K$500K$750K$1.0M2023 Q1: $130K2023 Q2: $150K2023 Q3: $156K2023 Q4: $223K20232024 Q1: $248K2024 Q2: $240K2024 Q3: $170K2024 Q4: $65K20242025 Q1: $80K2025 Q2: $50K2025 Q3: $200K2025 Q4: $170K20252026 Q1: $200K2026 Q2: $210K2026 Q3: $30K2026
  • TIBER CREEK GROUPCAREDX, INC. · 2026 Q4 · HCR—
    Filing ↗
  • TODD STRATEGY GROUPCAREDX, INC. · 2026 Q2 · MMM$60K
    Filing ↗
  • CAREDX, INC.CAREDX, INC. · 2026 Q3 · MMM, HCR$30K
    Filing ↗
  • TODD STRATEGY GROUPCAREDX, INC. · 2026 Q2 · MMM$60K
    Filing ↗
  • CAREDX, INC.CAREDX, INC. · 2026 Q2 · MMM, HCR$90K
    Filing ↗

Government Contracts

Federal awards to caredx · USAspending
$6.6MAwarded · 6 contracts on record
  • Department of Veterans AffairsALLOSURE IN-HOME PATIENT TESTING$142K
    Jan 15, 2027 · ↗
  • Department of Veterans AffairsALLOSURE KIDNEY TEST$236K
    Oct 19, 2022 · ↗
  • Department of Veterans AffairsLAB TESTS FOR POST TRANSPLANT CARE.$1.6M
    Apr 1, 2026 · ↗
  • Department of Veterans AffairsTRANSPLANT TESTING KITS$2.5M
    Sep 29, 2026 · ↗
  • Department of Veterans AffairsGENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)$1.0M
    Sep 23, 2026 · ↗
  • Department of Veterans AffairsALLOMAP AND ALLOSURE POST HEART TRANSPLANT REJECTION SURVEILLANCE TESTS SERVICES$1.1M
    Mar 1, 2022 · ↗

U.S. Patents

Recent USPTO applications naming CareDx, Inc.

No USPTO patent applications found for CareDx, Inc..

Annual Financials

From CDNA's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$379.8M$333.8M$280.3M$321.8M$296.4M
Operating income-$30.8M$40.8M-$203.4M-$77.2M-$29.7M
Net income-$21.4M$52.5M-$190.3M-$76.6M-$30.7M
Diluted EPS-$0.40$0.93-$3.54-$1.44-$0.59
Operating cash flow$42.0M$38.0M-$18.4M-$25.2M-$19.3M
Cash and equivalents$65.4M$114.7M$82.2M$89.9M$348.5M
Total assets$413.2M$491.1M$466.8M$543.0M$566.6M
Total liabilities$110.1M$112.6M$205.5M$112.1M$100.7M
Shareholders' equity$303.1M$378.4M$261.3M$430.9M$465.9M

As CareDx, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 25, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in CDNA's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureOct 29, 2026
    EDGAR ↗
  • 8-K/A · Items 2.01, 9.01Acquisition or dispositionSep 16, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 30, 2026
    EDGAR ↗
  • 8-K · Items 2.01, 7.01, 9.01Acquisition or disposition · Reg FD disclosureJul 7, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 15, 2026
    EDGAR ↗

About CareDx, Inc.

From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersBRISBANE, CA
IncorporatedDE
Former namesXDx, Inc., EXPRESSION DIAGNOSTICS INC